Arizona Regents recognize TGen with award for Outstanding Service to Higher Education

November 20, 2015

PHOENIX, Ariz. -- Nov. 20, 2015 -- The Arizona Board of Regents presented the Translational Genomics Research Institute (TGen) with its 2015 Regents' Award for Outstanding Service to Higher Education, recognizing the extensive research TGen has conducted in association with Northern Arizona University (NAU).

The award was presented at a Board of Regents dinner Thursday at the University of Arizona. The award was established in 1996 to recognize groups or individuals who make important and lasting contributions to the higher education system in Arizona.

TGen's Pathogen Genomics Division in Flagstaff, or TGen North, works hand-in-hand on numerous scientific investigations with NAU's Microbial Genetics & Genomics Center (MGGen), studying ways to bolster the nation's biodefense, and to prevent outbreaks -- even pandemics -- of such contagions as flu, cholera, E. coli, salmonella, and even the plague.

TGen North and MGGen are both directed by Dr. Paul Keim, TGen Professor and Cowden Endowed Chair of Microbiology at NAU, and a world-renowned expert in anthrax and other infectious diseases. Under his guidance, NAU undergraduates and graduate students gained invaluable experience on the way to launching their careers.

"This recognition by the Arizona Board of Regents is most welcome and reflects the hard work and ingenuity of countless researchers and students at both TGen and NAU," Dr. Keim said. "Through our joint NAU-TGen research, we are continuing to develop tools and technologies that have a great impact on human health."

Three patents have been awarded jointly to TGen and NAU, and 26 are pending. One of the patents is for a set of genetically based tests that accurately identify fungal pathogens that threaten public health worldwide. These tests allow for real-time analysis in labs, clinics, physician offices, emergency rooms and even field settings. They have great potential for saving lives and lowering health care costs.

Another patent is for a test that can detect, and assist in the treatment of, the H1N1 pandemic flu strain. The test quickly informs doctors about the strain of flu that is present and whether it is resistant to anti-viral drugs.

"The strong collaboration between TGen North and NAU is a prime example of what can be accomplished through close, synergetic efforts that compliment the best attributes and expertise of each institute," said Dr. Jeffrey Trent, TGen President and Research Director.

NAU President Rita Cheng praised TGen and Dr. Trent: "Since its founding in 2002, TGen has grown to become a cornerstone of Arizona's influential bioscience sector, in no small part due to the vision and leadership of Jeff Trent. I thank him for his foresight in appreciating the value of Arizona's regents' institutions as research assets and centers of knowledge."

TGen North also collaborates with local, national and international universities, biotech companies, security agencies, health care providers, public health departments and other institutions in its quest to protect human health.

"With this great TGen-NAU partnership, we are translating advanced education directly into advanced research and, in turn, directly into advancements in human health. We are grateful for this relationship and look forward to creating even more positive outcomes together," said Dr. David Engelthaler, TGen Associate Professor and Director of Programs and Operations at TGen North.

The Arizona Board of Regents is the governing body of Arizona's public university system, providing policy guidance to Arizona State University, Northern Arizona University, the University of Arizona and their branch campuses.

"Nominees for this year's Regents' Awards for Outstanding Service to Higher Education were exemplary," said Regent Ram Krishna, vice-chair of the Regents' Award Nomination Committee. "TGen demonstrates the tremendous power of collaboration with Northern Arizona University as well as the impact of the biosciences on Arizona's economy and the health of its citizens. It is our honor to give this award to TGen."

TGen was nominated for the Regents award on NAU's behalf by former Regent Jack Jewett, now President and CEO of the Flinn Foundation.
About TGen

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: Follow TGen on Facebook, LinkedIn and Twitter @TGen.

Press Contact:
Steve Yozwiak
TGen Senior Science Writer

The Translational Genomics Research Institute

Related Infectious Diseases Articles from Brightsurf:

Understanding the spread of infectious diseases
Physicists at M√ľnster University (Germany) have shown in model simulations that the COVID-19 infection rates decrease significantly through social distancing.

Forecasting elections with a model of infectious diseases
Election forecasting is an innately challenging endeavor, with results that can be difficult to interpret and may leave many questions unanswered after close races unfold.

COVID-19 a reminder of the challenge of emerging infectious diseases
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).

Certain antidepressants could provide treatment for multiple infectious diseases
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.

Opioid epidemic is increasing rates of some infectious diseases
The US faces a public health crisis as the opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.

Infectious diseases could be diagnosed with smartphones in sub-Saharan Africa
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.

The Lancet Infectious Diseases: Experts warn of a surge in vector-borne diseases as humanitarian crisis in Venezuela worsens
The ongoing humanitarian crisis in Venezuela is accelerating the re-emergence of vector-borne diseases such as malaria, Chagas disease, dengue, and Zika virus, and threatens to jeopardize public health gains in the country over the past two decades, warn leading public health experts.

Glow-in-the-dark paper as a rapid test for infectious diseases
Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

Math shows how human behavior spreads infectious diseases
Mathematics can help public health workers better understand and influence human behaviors that lead to the spread of infectious disease, according to a study from the University of Waterloo.

Many Americans say infectious and emerging diseases in other countries will threaten the US
An overwhelming majority of Americans (95%) think infectious and emerging diseases facing other countries will pose a 'major' or 'minor' threat to the U.S. in the next few years, but more than half (61%) say they are confident the federal government can prevent a major infectious disease outbreak in the US, according to a new national public opinion survey commissioned by Research!America and the American Society for Microbiology.

Read More: Infectious Diseases News and Infectious Diseases Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to